Trials / Completed
CompletedNCT00421135
A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Alaunos Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZIO-201 | ZIO-201 as a single dose given once every 21 days. This is a dose escalation arm. |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2007-10-01
- Completion
- 2007-10-01
- First posted
- 2007-01-11
- Last updated
- 2009-09-17
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00421135. Inclusion in this directory is not an endorsement.